Richard B. Hancock is Director at Avid Bioservices, Inc. (CDMO). They have made 18 open-market trades across 1 company since 2019, most recently 2025-02-05.
CIK 0001723288
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $640K since 2019, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CDMO | 124,191 | $1.6M |
Shares reported on the most recent Form 4, priced at the 2025-01-29 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CDMO | BUY | 2023-12-15 | 2023-12-18 | $5.86 | $135K | +2.0% | -1.7% | +3.6% |
| CDMO | BUY | 2023-12-13 | 2024-01-10 | $5.21 | $404K | +0.0% | +0.0% | +7.0% |
| CDMO | SELL · 10b5-1 | 2023-06-06 | 2023-06-08 | $16.37 | $163K | -9.1% | -18.0% | -28.8% |
| CDMO | SELL · 10b5-1 | 2023-05-01 | 2023-05-02 | $17.92 | $179K | -1.9% | -11.8% | -28.4% |
| CDMO | SELL · 10b5-1 | 2023-04-03 | 2023-04-05 | $18.46 | $92K | +0.1% | -2.4% | -26.6% |
| CDMO | SELL | 2023-03-01 | 2023-03-03 | $16.59 | $83K | +2.0% | +9.5% | -9.0% |
| CDMO | SELL | 2023-02-01 | 2023-02-03 | $16.02 | $80K | +4.1% | -0.5% | +13.7% |
| CDMO | SELL · 10b5-1 | 2023-01-12 | 2023-01-13 | $16.00 | $80K | -1.0% | +1.5% | +29.5% |
| CDMO | SELL | 2022-12-02 | 2022-12-06 | $16.11 | $161K | +4.1% | +6.2% | +21.8% |
| CDMO | SELL | 2022-10-03 | 2022-10-05 | $18.32 | $158K | +1.2% | -25.1% | -26.3% |
| CDMO | SELL | 2022-09-01 | 2022-09-02 | $17.12 | $108K | +20.4% | +10.3% | -0.8% |
| CDMO | SELL | 2022-08-01 | 2022-08-02 | $19.40 | $97K | +2.1% | -9.3% | -12.2% |
| CDMO | SELL | 2022-07-05 | 2022-07-06 | $16.03 | $80K | +3.2% | +15.4% | +11.7% |
| CDMO | SELL | 2022-06-24 | 2022-06-28 | $16.06 | $282K | +16.7% | +34.1% | +17.0% |
| CDMO | SELL | 2022-04-01 | 2022-04-05 | $21.21 | $106K | -7.7% | -32.2% | -15.1% |
| CDMO | SELL | 2022-03-01 | 2022-03-03 | $19.86 | $99K | +2.7% | +12.9% | -29.1% |
| CDMO | SELL | 2022-02-01 | 2022-02-03 | $18.80 | $158K | +14.7% | -3.2% | -23.0% |
| CDMO | SELL | 2022-01-03 | 2022-01-05 | $27.53 | $138K | -16.2% | -16.2% | -15.4% |
| CDMO | SELL | 2021-12-01 | 2021-12-03 | $30.90 | $155K | -9.4% | -2.1% | -32.4% |
| CDMO | SELL | 2021-11-15 | 2021-11-17 | $32.46 | $324K | -7.9% | -21.6% | -35.2% |
| CDMO | BUY | 2020-03-13 | 2020-03-16 | $3.99 | $50K | +31.0% | +8.7% | +58.6% |
| CDMO | BUY | 2019-09-10 | 2019-09-12 | $5.09 | $51K | +0.9% | -4.0% | +31.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.